Skip to main content
Caplight Logo









Achira

Achira

Private
New York City, New YorkHealthcare & Life Scienceshttps://achira.ai/

Last Round

Seed

Feb 21, 2025

Total Funding Raised

$33.06M

Company Overview

Achira operates in Healthcare & Life Sciences and is based in New York City, New York. Its latest recorded funding round was a Seed round in February 2025.

Achira is a biotechnology company that develops atomistic foundation simulation models to power the future of drug discovery.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology, Advanced Materials, Synthetic Data, Medical AI

Business Model

B2B

Customer Profile

Services & Consulting, Subscription SaaS

AI Layer

Foundation

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

Achira Comparables

Compare Achira with similar companies based on industry and business-model similarity.

Achira comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Variational AI
81%
Chai Discovery
81%
Genesis Molecular AI
79%
Book a demo to see all comparables

For institutional investors. Book with your work email.

Achira Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedFeb 21, 2025
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Key People

Founding team and executive leadership

John Chodera

Co-Founder, CEO, and President

Founding Team

Daniel Smith

Chief Technology Officer

Executive Team

For institutional investors. Book with your work email.

Achira Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 18, 2026

    Monthly visitors increased 228% MoM, reaching 13.7K.

  • Apr 25, 2026

    Grew 20% QoQ from 15 to 18 employees.

Book a demo to see all signals

For institutional investors. Book with your work email.

Achira Filings

Explore SEC and related filing metadata, where available.

Achira filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about Achira's valuation, stock price, and market status.

Is Achira a public or private company?

Achira is a private company.

What is the current stock price of Achira?

Achira is a private company, so its shares have no public market price. Caplight tracks Achira's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Achira worth (valuation)?

Valuation information for Achira is not publicly available.

Can I buy Achira stock?

Achira shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Achira's last funding round?

Achira's most recent funding round was Seed on February 21, 2025.

Who are the main investors in Achira?

Key investors in Achira include Dimension.

Will Achira IPO soon?

No public IPO plans have been announced for Achira.

How can I track Achira secondary market activity?

Caplight tracks bids, offers, and trades in Achira's shares on secondary markets.

Firmographic Details

HeadquartersNew York City, New York
Employee Range18
Year Founded2024
Last FundingFeb 21, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?